methylhydroxynandrolone mohn mhn also known hmnt well synthetic orally active steroid aas derivative nandrolone never first described studied treatment breast cancer introduced clinical drug reemerged started sold internet dietary mohn joined aas controlled substance united states january mohn nonaromatizable due presence hydroxy group position reason poses risk estrogenic side effects like gynecomastia dosage unlike many also inhibited hydroxy group mohn mohn may relatively higher ratio androgenic anabolic activity nandrolone derivatives opposite case aas decreases aas potency nandrolone early assays found mohn approximately times anabolic activity times androgenic activity mohn derivative normethandrone derivative oxabolone derivative nandrolone analogue oxymesterone article steroid stub help wikipedia expanding drug article relating genitourinary system stub help wikipedia expanding httpsenwikipediaorgwikimethylhydroxynandrolone